Drug—drug interactions that should be non-interruptive in order to reduce alert fatigue in electronic health records

作者: Shobha Phansalkar , Heleen van der Sijs , Alisha D Tucker , Amrita A Desai , Douglas S Bell

DOI: 10.1136/AMIAJNL-2012-001089

关键词:

摘要: Objective Alert fatigue represents a common problem associated with the use of clinical decision support systems in electronic health records (EHR). This is particularly profound drug–drug interaction (DDI) alerts for which studies have reported override rates approximately 90%. The objective this study to report consensus-based recommendations an expert panel on DDI that can be safely made non-interruptive provider's workflow, EHR, attempt reduce alert fatigue. Methods We utilized process rate interactions. Panelists had expertise medicine, pharmacy, pharmacology and informatics, represented both academic institutions vendors medication knowledge bases EHR. In addition, representatives from US Food Drug Administration American Society Health-System Pharmacy contributed discussions. Results Recommendations considerations resulted creation list 33 class-based low-priority do not warrant being interruptive one institution, these accounted 36% interactions displayed. Discussion Development customization content drive alerting resource-intensive task. Creation standardized may help across EHR. Conclusions Future efforts might include development consortium maintain over time. Such could also used conjunction financial incentives tied its adoption

参考文章(24)
Josh F. Peterson, David W. Bates, Preventable medication errors: identifying and eliminating serious drug interactions. Journal of the American Pharmaceutical Association. ,vol. 41, pp. 159- 160 ,(2001) , 10.1016/S1086-5802(16)31243-8
Philip D. Hansten, John R. Horn, Thomas K. Hazlet, ORCA: OpeRational ClassificAtion of Drug Interactions Journal of the American Pharmaceutical Association. ,vol. 41, pp. 161- 165 ,(2001) , 10.1016/S1086-5802(16)31244-X
Robyn Tamblyn, Laurel K Taylor, Reasons for physician non-adherence to electronic drug alerts. Studies in health technology and informatics. ,vol. 107, pp. 1101- 1105 ,(2004)
Thomas K. Hazlet, Todd A. Lee, Philip D. Hansten, John R. Horn, Performance of Community Pharmacy Drug Interaction Software Journal of the American Pharmaceutical Association. ,vol. 41, pp. 200- 204 ,(2001) , 10.1016/S1086-5802(16)31230-X
Hhm Erik Korsten, Rje Rene Grouls, Amjw Anne-Marie Scheepers-Hoeks, C Neef, Strategy for implementation and First results of advanced clinical decision support in hospital pharmacy practice Studies in health technology and informatics. ,vol. 148, pp. 142- 148 ,(2009) , 10.3233/978-1-60750-043-8-142
A. K. Jha, J. Laguette, A. Seger, D. W. Bates, Can Surveillance Systems Identify and Avert Adverse Drug Events? A Prospective Evaluation of a Commercial Application Journal of the American Medical Informatics Association. ,vol. 15, pp. 647- 653 ,(2008) , 10.1197/JAMIA.M2634
Davide Bolchini, Jon D. Duke, A successful model and visual design for creating context-aware drug-drug interaction alerts. american medical informatics association annual symposium. ,vol. 2011, pp. 339- 348 ,(2011)
P. Nohama, G. J. Kuperman, D. W. Bates, B. H. Rocha, G. Del Fiol, Comparison of two knowledge bases on the detection of drug-drug interactions. american medical informatics association annual symposium. pp. 171- 175 ,(2000)
Eva K. Lee, Tal Senior, Amanda F. Mejia, James Jose, Improving Patient Safety through Medical Alert Management: An Automated Decision Tool to Reduce Alert Fatigue american medical informatics association annual symposium. ,vol. 2010, pp. 417- 421 ,(2010)
Saul N. Weingart, Brett Simchowitz, Lawrence Shiman, Daniela Brouillard, Adrienne Cyrulik, Roger B. Davis, Thomas Isaac, Michael Massagli, Laurinda Morway, Daniel Z. Sands, Justin Spencer, Joel S. Weissman, Clinicians' Assessments of Electronic Medication Safety Alerts in Ambulatory Care Archives of Internal Medicine. ,vol. 169, pp. 1627- 1632 ,(2009) , 10.1001/ARCHINTERNMED.2009.300